Sun Pharmaceutical Industries is a global pharmaceutical company headquartered in India. It is one of the largest specialty generic pharmaceutical companies in the world, with a significant presence in over 100 countries. The company focuses on a wide range of therapeutic areas, including cardiology, psychiatry, neurology, gastroenterology, and diabetology, among others.

Sun Pharma is committed to delivering high-quality, affordable medicines to patients worldwide. The company invests heavily in research and development to innovate and improve its product offerings. With a robust pipeline of new products, Sun Pharma continues to expand its portfolio and market reach.

In terms of sustainability, Sun Pharmaceutical Industries has made strides in reducing its environmental impact. The company has implemented various initiatives to enhance energy efficiency, reduce waste, and minimize water usage across its manufacturing facilities. Sun Pharma is also working towards reducing its carbon footprint by adopting renewable energy sources and optimizing its supply chain operations.

However, detailed information on specific sustainability certifications or ESG reports for Sun Pharmaceutical Industries is limited. The company continues to focus on integrating sustainable practices into its operations, aiming to contribute positively to the environment and society.